Clinical Professor, Department of Medicine
Biosketch
Tim Fischell, MD is a physician at the Borgess Heart Institute. Dr. Fischell earned his medical degree in 1981 from Cornell University and completed an internal medicine residency in 1984 at Massachusetts General Hospital. De. Fischell also went onto complete two fellowships at Standford University, one in cardiology in 1986 and the other in interventional cardiology in 1987.
-
Board Certification
- American Board of Internal Medicine (Interventional Cardiology)
- American Board of Internal Medicine (Internal Medicine)
- American Board of Internal Medicine (Cardiovascular Disease)
-
Education and Training
- Fellowship 1987, Interventional Cardiology, Medical Center, Stanford University
- Fellowship 1986, Cardiology, Medical Center, Stanford University
- Residency 1984, Medicine, Massachusetts General Hospital,
- MD 1981, Medical College, Cornell University
- AB 1978, College Scholar, concentration in Neurobiology/Psychology, Cornell University
-
Research
- Cardiology
-
Publications
Banga S., Abela G.S., Saltiel F., Fischell T., Kalavakunta J.K., Sood A., Jolly G., Najib K., Al-Ali H., Qintar M., Bazil J., Singh Y., Gupta V. Management of Atrial Fibrillation Post Transcatheter Aortic Valve Implantation American Journal of Cardiology. 2023;200:171-177.
Fischell T.A. Editorial: Intracoronary Brachytherapy for In-Stent Restenosis: Not Bad in the Sprint, But Fails in the Marathon Cardiovascular Revascularization Medicine. 2023;54:5-6.
Pathak A., Rudolph U.M., Saxena M., Zeller T., Müller-Ehmsen J., Lipsic E., Schmieder R.E., Sievert H., Halbach M., Sharif F., Parise H., Fischell T.A., Weber M.A., Kandzari D.E., Mahfoud F. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications EuroIntervention. 2023;19:602-611.
Ponna P.K., Gonuguntla A., Botta R.K., Fischell T., Agrawal Y. Shockwave Lithotripsy of Calcific Stenosis of the Distal Abdominal Aorta to Facilitate Transcatheter Aortic Valve Replacement Cardiovascular Revascularization Medicine. 2023;53:S134-S138.
Abbott J.D., Adams G., Alaswad K., Anderson H.V., Arain S., Aronow H., Bersin R., Brown C., Collins T., Cowley M., Fischell T., Garratt K., Greenbaum A., Grines C., Helmy T., Henry T., Lerman A., Lucas V., Magd A., Marshall J., Meduri C., Mustapha J., Naidu S., Nikol S., Ohman E.M., O'Neill W., Patel R., Rinaldi M., Sanchez C., Sathananthan J., Smalling R., Shah B., Szerlip M., Vetrovec G., Weiner B., Zidar J. Clinical Conference Proceedings: IAGS 2022 Summary Document: 16th Biennial Meeting of the International Andreas Gruentzig Society held January 31-February 3, 2022 in Punta Cana, Dominican Republic The Journal of invasive cardiology. 2022;34:E524-E573.
Fischell T.A. The Emperor's New Clothes: Dispelling the Myth of Improved Safety With Bare Metal Cardiovascular Revascularization Medicine. 2022;35:74-75.
Kassab K., Kassier A., Fischell T.A. Intracoronary Lithotripsy Use for In-Stent Restenosis, Including Multilayer ISR Cardiovascular Revascularization Medicine. 2022;44:10-13.
Kassab K., Soni R., Kassier A., Fischell T.A. The Potential Role of Renal Denervation in the Management of Heart Failure Journal of Clinical Medicine. 2022;11
Kassier A., Fischell T.A. Managing coronary artery perforation after percutaneous coronary intervention Expert Review of Cardiovascular Therapy. 2022;20:215-222.
Persu A., Maes F., Toennes S.W., Ritscher S., Georges C., Wallemacq P., Haratani N., Parise H., Fischell T.A., Lauder L., Mahfoud F. Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation Blood Pressure. 2022;31:109-117.
Bertog S., Sharma A., Mahfoud F., Pathak A., Schmieder R.E., Sievert K., Papademetriou V., Weber M.A., Haratani N., Lobo M.D., Saxena M., Kandzari D.E., Fischell T.A., Sievert H. Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter Cardiovascular Revascularization Medicine. 2021;24:77-86.
De Maria G.L., Garcia-Garcia H.M., Scarsini R., Finn A., Sato Y., Virmani R., Bhindi R., Ciofani J.L., Nuche J., Ribeiro H.B., Mathias W., Yerasi C., Fischell T.A., Otterspoor L., Ribichini F., Ibañez B., Pijls N.H.J., Schwartz R.S., Kapur N.K., Stone G.W., Banning A.P. Novel device-based therapies to improve outcome in ST-segment elevation myocardial infarction European Heart Journal: Acute Cardiovascular Care. 2021;10:687-697.
Fischell T.A. Is “Non-Inferiority” Good Enough? Approaching the Asymptote in DES Cardiovascular Revascularization Medicine. 2021;31:7-9.
Fischell T.A., Payne J., Wehde K., Saltiel F.S. A Next-Generation Guide Extension System for Percutaneous Coronary Intervention Cardiovascular Revascularization Medicine. 2021;32:50-55.
Mahfoud F., Bertog S., Lauder L., Böhm M., Schmid A., Wojakowski W., Parise H., Fischell T.A., Kandzari D.E., Pathak A., Persu A., Sievert H. Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location Catheterization and Cardiovascular Interventions. 2021;98:E832-E838.
Mahfoud F., Sievert H., Bertog S., Lauder L., Ewen S., Lengelé J.P., Wojakowski W., Schmieder R., Van Der Giet M., Weber M.A., Kandzari D.E., Parise H., Fischell T.A., Pathak A., Persu A. Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension Circulation: Cardiovascular Interventions. 2021;14:E010075.
Mahfoud F., Weber M., Schmieder R.E., Lobo M.D., Blankestijn P.J., Persu A., Fischell T.A., Parise H., Pathak A., Kandzari D.E. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications American Heart Journal. 2021;239:90-99.
Randhawa M.S., Fischell T.A. Unusual gastric contrast extravasation after coronary angiography Journal of Invasive Cardiology. 2021;33:E489.
Fischell T.A. Not a Small Problem: Is the COMBO Stent a Solution to the Challenges of DES in Small Vessels? Cardiovascular Revascularization Medicine. 2020;21:1548-1549.
Fischell T.A., Balmuri A., Agarwal S., Verhye S. Integrated Stent Delivery System: A Next Generation of Stent Delivery and Drug-Eluting Stent Cardiovascular Revascularization Medicine. 2020;21:205-212.
Janas A., Król M., Hochuł M., Jochymczyk M., Hayward-Costa C., Parise H., Haratani N., Fischell T., Wojakowski W. Evaluation of transcatheter alcohol-mediated perivascular renal denervation to treat resistant hypertension Journal of Clinical Medicine. 2020;9:1-12.
Fischell T. Continued Momentum in Catheter-Based Renal Denervation: The More the Merrier—Better Denervation Wins Again Cardiovascular Revascularization Medicine. 2019;20:2-3.
Holmes D.R., Krucoff M.W., Mullin C., Mikdadi G., Presser D., Wohns D., Kaplan A., Ciuffo A., Eberly A.L., Iteld B., Fischell D.R., Fischell T., Keenan D., John M.S., Gibson C.M. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events Journal of the American College of Cardiology. 2019;74:2047-2055.
Bertog S., Fischell T.A., Vega F., Ghazarossian V., Pathak A., Vaskelyte L., Kent D., Sievert H., Ladich E., Yahagi K., Virmani R. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model EuroIntervention. 2017;12(15):e1898-e1906.
Fischell T.A. Editorial: The “JET” technique for provisional side-branch stenting back to the future, and in the right direction Journal of Interventional Cardiology. 2017;30(6):535-536.
Fischell T. Editorial: Can Renal Denervation Work? Yes, But First One Must Denervate. Lessons from Human Renal Sympathetic Nerve Anatomy Journal of Interventional Cardiology. 2016;29(6):601-602.
Fischell T. Reply: Chemical Renal Denervation Revisited JACC: Cardiovascular Interventions. 2016;9(12):1307-1308.
Fischell T.A., Ebner A., Gallo S., Ikeno F., Minarsch L., Vega F., Haratani N., Ghazarossian V.E. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience JACC: Cardiovascular Interventions. 2016;9(6):589-598.
Fischell D.R., Fischell T.A., Ghazarossian V. Peregrine System <sup>TM</sup> Infusion Catheter for Perivascular Renal Denervation Journal of Medical Devices, Transactions of the ASME. 2015;9(2):1-2.
Fischell T., Fischell D., Ghazarossian V., Vega F., Ebner A. Next generation renal denervation: Chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter Cardiovascular Revascularization Medicine. 2015;16(4):221-227.
Fischell T., Ghazarossian V., Vega F. Perivascular renal denervation (pvrd™): chemical renal denervation with micro-doses of ethanol using the peregrine™ renal denervation device Renal Denervation: A New Approach to Treatment of Resistant Hypertension. 2015:107-116.
Lewis B.S., Ophuis T.O., Jukema J.W., De Ferrari G.M., Ruzyllo W., De Lucca P., Im K.A., Bohula E.A., Reist C., Wiviott S.D., Tershakovec A.M., Musliner T.A., Braunwald E., Califf R.M., Musliner T., Tershakovec A., Gurfinkel E., Aylward P., Tonkin A., Maurer G., Van de Werf F., Nicolau J., Genest J., Armstrong P., Corbalan R., Isaza D., Spinar J., Grande P., Voitk J., Kesaniemi A., Bassand J., Farnier M., Keltai M., Mathur A., Mittal S., Reddy K., White H., Pedersen T., Britto F., Carrageta M., Duris T., Dalby A., Seung K., Lopez-Sendon J., Dellborg M., Mach F., Guneri S., Parkhomenko A., Brady A., Ballantyne C., de Lemos J., Kleiman N., McGuire D., Centeno E., Casalins M., Cartasegna L., Beltrano M., Guerrero R., Fanuele M., Berra F., Egido J., Colombo H., Dellatorre M., Terns P., Blumberg E., Reges P., Azize G., Ramos H., Fernandez R., Carlessi C., Milesi R., Schmuck R., Duronto E., Procopio G., Carlevaro O., Maffeo H., Beloscar J., Viso M., Hominal M., Castoldi M., Bluguermann J., Mauro D., Macin S., Cocco N., Ruiz N., Ricart J., Lozada A., Nani S., Turri D., Fernandez H., Caruso O., Zarandon R., Bono J. Ezetimibe added to statin therapy after acute coronary syndromes New England Journal of Medicine. 2015;372(25):2387-2397.
Gibson M., Krucoff M., Fischell D., Fischell T.A., Keenan D., Abueg C., Patel C., Holmes D. Rationale and design of the AngeLmed for early recognition and treatment of STEMI trial: A randomized, prospective clinical investigation American Heart Journal. 2014;168(2):168-174.
Shah I., Khan S.O., Malhotra S., Fischell T. Erratum: Eptifibatide: The evidence for its role in the management of acute coronary syndromes (Core Evidence (2009) 4 (49-65)) Core Evidence. 2014;9:49.
Fischell T.A., Vega F., Raju N., Johnson E.T., Kent D.J., Ragland R.R., Fischell D.R., Almany S., Ghazarossian V.E. Ethanol-mediated perivascular renal sympathetic denervation: Preclinical validation of safety and efficacy in a porcine model EuroIntervention. 2013;9(1):140-147.
Giugliano R.P., Ruff C.T., Braunwald E., Murphy S.A., Wiviott S.D., Halperin J.L., Waldo A.L., Ezekowitz M.D., Weitz J.I., Špinar J., Ruzyllo W., Ruda M., Koretsune Y., Betcher J., Shi M., Grip L.T., Patel S.P., Patel I., Hanyok J.J., Mercuri M., Antman E.M., Peruzzotti-Jametti L., Malynovsky Y., Morin S.E., Hoffman E.B., Deenadayalu N., Lanz H., Curt V., Duggal A., Davé J., Morgan D., Choi Y., Jin J., Xie J., Crerand W., Kappelhof J., Maxwell W., Skinner M., Selicato G., Otto C., Reissner C., Smith K., Ostroske J., Ron A., Connolly S., Camm J., Paolasso E., Aylward P., Heidbuchel H., Nicolau J.C., Goudev A., Roy D., Corbalán R., Yang Y., Botero R., Bergovec M., Grande P., Hassager C., Voitk J., Huikuri H., Nieminen M., Blanc J.J., LeHeuzey J.Y., Mitrovic V., Alexopoulos D., Sotomora G., Kiss R., SomaRaju B., Lewis B., Merlini P., Metra M., Yamashita T., García-Castillo A., Ophuis T., White H., Atar D., Horna M., Babilonia N., Morais J., Dorobantu M., Ostojic M., Duris T., Dalby A., Chung N., Zamorano J.L., Juul-Möller S., Moccetti T., Chen S.A., Sritara P., Oto A., Parkhomenko A., Senior R., Verheugt F., Skene A., Anderson J., Bauer K., Easton J.D., Goto S., Lowe C. Edoxaban versus warfarin in patients with atrial fibrillation New England Journal of Medicine. 2013;369:2093-2104.
Hopenfeld B., John M.S., Fischell T.A., Johnson S.R. A statistically based acute ischemia detection algorithm suitable for an implantable device. Annals of biomedical engineering. 2012;40(12):2627-2638.
Dishmon D., Elhaddi A., Packard K., Gupta V., Fischell T. High incidence of inaccurate stent placement in the treatment of coronary aorto-ostial disease Journal of Invasive Cardiology. 2011;23:322-326.
Fischell T., Moualla S., Mannem S. Intracoronary thrombin injection using a microcatheter to treat guidewire-induced coronary artery perforation Cardiovascular Revascularization Medicine. 2011;12(5):329-333.
Fischell T.A., Fischell D.R., Avezum A., John M.S., Holmes D., Foster M., Kovach R., Medeiros P., Piegas L., Guimaraes H., Gibson C.M. Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia Journal of the American College of Cardiology. 2010;56(14):1089-1098.
Paulus B.M., Fischell T.A. Retrieval devices and techniques for the extraction of intravascular foreign bodies in the coronary arteries Journal of Interventional Cardiology. 2010;23(3):271-276.
Turk M., Gupta V., Fischell T.A. Evaluation of balloon withdrawal forces with bare-metal stents, compared with taxus™ and cypher™ drug-eluting coronary stents: Balloon, stent and polymer interactions Journal of Invasive Cardiology. 2010;22:113-116.
Collingwood R., Bermudez E., Fischell T.A. Comparison between three-dimensional angiographic reconstruction and intravascular ultrasound imaging for the measurement of cross-sectional luminal dimensions in intermediate coronary lesions Journal of Interventional Cardiology. 2009;22(3):277-281.
Collingwood R., Bermudez E., Fischell T.A. Erratum: Comparison between three-dimensional angiographic reconstruction and intravascular ultrasound imaging for the measurement of cross-sectional luminal dimensions in intermediate coronary lesions (Journal of Interventional Cardiology (2009) 3 (227-281) DOI: 10.1111/j.1540-8183.2009.00448.x) Journal of Interventional Cardiology. 2009;22(6):578.
Fischell T. The No Reflow Phenomenon: Etiology, Prophylaxis, and Treatment Pharmacology in the Catheterization Laboratory. 2009:217-226.
Fischell T. Contrast Loaded With N-Acetylcysteine for Coronary Imaging During Percutaneous Coronary Intervention. A New Concept for Renal and Myocardial Protection During Percutaneous Coronary Intervention JACC: Cardiovascular Interventions. 2009;2(3):222-223.
Fischell T.A., Saltiel F.S., Foster M.T., Wong S.C., Dishman D.A., Moses J. Initial clinical experience using an ostial stent positioning system (Ostial Pro™) for the accurate placement of stents in the treatment of coronary aorto-ostial lesions Journal of Invasive Cardiology. 2009;21(2):53-59.
Goldstein J.A., Grines C., Fischell T., Virmani R., Rizik D., Muller J., Dixon S.R. Coronary Embolization Following Balloon Dilation of Lipid-Core Plaques JACC: Cardiovascular Imaging. 2009;2(12):1420-1424.
Shah I., Khan S., Malhotra S., Fischell T. Eptifibatide: The evidence for its role in the management of acute coronary syndromes Core Evidence. 2009;4:49-65.
Fischell T. High-dose, bolus-only, glycoprotein IIb/IIIa inhibitors for elective coronary intervention: Logical, safe, cost-effective, and it works! Journal of Invasive Cardiology. 2008;20(2):59-60.
Fischell T. Plaque Prolapse After Stenting in Myocardial Infarction: Bad Plaque-Bad Omen?<sup>*</sup>*Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. JACC: Cardiovascular Imaging. 2008;1(4):498-499.
Fischell T., Haller S., Pulukurthy S., Virk I. Nicardipine and adenosine "flush cocktail" to prevent no-reflow during rotational atherectomy Cardiovascular Revascularization Medicine. 2008;9(4):224-228.
Fischell T.A. Pharmaceutical interventions for the management of no-reflow Journal of Invasive Cardiology. 2008;20(7):374-379.
Fischell T.A., Malhotra S., Khan S. A new ostial stent positioning system (Ostial Pro™) for the accurate placement of stents to treat aorto-ostial lesions Catheterization and Cardiovascular Interventions. 2008;71(3):353-357.
Fischell T., Subraya R., Ashraf K., Perry B., Haller S. "Pharmacologic" distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. The Journal of invasive cardiology. 2007;19(2):58-62.
Fischell T.A., Holmes D.R. Late DES thrombosis: A lot of smoke, very little fire? Catheterization and Cardiovascular Interventions. 2007;69(4):609-615.
Moses J.W., Weisz G., Mishkel G., Caputo R., O'Shaughnessey C., Wong S.C., Fischell T.A., Mooney M., Williams D.O., Popma J.J., Fitzgerald P., Smith S., Kuntz R.E., Collins M., Cohen S., Leon M.B. The SIRIUS-DIRECT Trial: A multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions Catheterization and Cardiovascular Interventions. 2007;70(4):505-512.
Fischell T., Attia T., Rane S., Salman W. High-dose, single-bolus eptifibatide: A safe and cost-effective alternative to conventional glycoprotein IIb/IIIa inhibitor use for elective coronary interventions Journal of Invasive Cardiology. 2006;18(10):487-491.
Fischell T., Carter A., Ashraf K., Birdsall J., Smoker S. Coronary artery rupture during balloon angioplasty, rescued with localized thrombin injection and coil embolization Catheterization and Cardiovascular Interventions. 2006;68(2):254-257.
Fischell T.A. "Bolus-only" glycoprotein IIb/IIIa inhibitor use for elective percutaneous coronary intervention. Maybe less is more? American Heart Journal. 2006;152(5):812-814.
Fischell T.A., Fischell D.R., Fischell R.E., Virmani R., DeVries J.J., Krucoff M.W. Real-Time Detection and Alerting for Acute ST-Segment Elevation Myocardial Ischemia Using an Implantable, High-Fidelity, Intracardiac Electrogram Monitoring System With Long-Range Telemetry in an Ambulatory Porcine Model Journal of the American College of Cardiology. 2006;48(11):2306-2314.
Belardi J., Cowley M., Fischell T., Cates C., Rodriguez A., Sperling D., Fischell R., Braden G., Jacobs J. Drug-eluting stents: Current limitations Journal of Invasive Cardiology. 2005;17(6)
Costa M., Angiolillo D., Teirstein P., Gilmore P., Leon M., Moses J., Yakubov S., Carter A., Fischell T., Zenni M., Bass T. Sirolimus-eluting stents for treatment of complex bypass graft disease: Insights from the SECURE registry Journal of Invasive Cardiology. 2005;17(8):396-398.
Fischell T., Carter A. Unprotected left main stenting: An alternative to CABG in a DES world? Journal of Invasive Cardiology. 2005;17(3):129-130.
Fischell T., Haller S., Ashraf K. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervantion Journal of Invasive Cardiology. 2005;17(6):334-337.
Fischell T., Maheshwari A., Mirza R., Haller S., Carter A., Popma J. Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting Catheterization and Cardiovascular Interventions. 2005;64(4):460-467.
Fischell T.A., Fischell D.R., Fischell R., Baskerville S., Hendrick S., Moshier C., Harwood J.P., Krucoff M.W. Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion Cardiovascular Revascularization Medicine. 2005;6(1):14-20.
Lerman A., Vogel J., Fischell T., Leimgruber P., Firth B. IAGS proceedings. The biology of plaque and patient vulnerability. Panel discussion. The Journal of invasive cardiology. 2005;17(4):239-242.
Fischell T., Maheshwari A. Current applications for nicardipine in invasive and interventional cardiology Journal of Invasive Cardiology. 2004;16(8):428-432.
Gupta V., Aravamuthan B., Baskerville S., Smith S., Lauer M., Fischell T. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, "real world" registry Journal of Invasive Cardiology. 2004;16:304-310.
Holmes D., Leon M., Moses J., Popma J., Cutlip D., Fitzgerald P., Brown C., Fischell T., Wong S., Midei M., Snead D., Kuntz R. Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis Circulation. 2004;109(5):634-640.
Fischell T.A., Harrington R.A., Waksman R., Bleich S. How would you manage this case? Journal of Invasive Cardiology. 2003;15(9):517-518.
Fischell T.A., Korban E.H., Lauer M. Successful treatment of distal coronary guidewire-induced perforation with balloon catheter delivery of intracoronary thrombin Catheterization and Cardiovascular Interventions. 2003;58(3):370-374.
Mehran R., Aymong E.D., Ashby D.T., Fischell T., Whitworth H., Siegel R., Thomas W., Wong S.C., Narasimaiah R., Lansky A.J., Leon M.B. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: Final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study Circulation. 2003;108(9):1078-1083.
Fischell D.R., Fischell T.A., Fischell R., Tepe G., Wiskirchen J. Radioisotope stents Minimally Invasive Therapy and Allied Technologies. 2002;11(4):149-155.
Hehrlein C., DeVries J., Arab A., Haller S.D., Kloostra A., Lauer M., Foster M.T., Fischell T.A. Role of the "dogbone" effect of balloon-expandable stents: quantitative coronary analysis of DUET and NIR stent implantation introducing a novel indexing system. The Journal of invasive cardiology. 2002;14(2):59-65.
Prieto A.R., Przybysz A., Fischell T.A. Long balloon angioplasty with focal stenting for the treatment of diffuse coronary artery disease Catheterization and Cardiovascular Interventions. 2002;57(4):437-443.
Zidar J.P., Whitworth H., Gonschior P., Beyer-Enke S., De la Fuente L., Bonan R., O'Murchu B., Lowe R., Zidar J., Zeitler E., Myler R., Garratt K., Fischell T., Belardi J., LaViolette P., Linnemeier T., Cohen H., Werner J., Cates C. Resolving existing restenosis Journal of Invasive Cardiology. 2002;14(11):702-707.
Fischell D.R., Fischell T.A., Fischell R. The Bx velocity™ stent Handbook of Coronary Stents, Fourth Edition. 2001:40-48.
Fischell T.A., Virmani R. Intracoronary brachytherapy in the porcine model a different animal Circulation. 2001;104(20):2388-2390.
Hehrlein C., DeVries J.J., Arab A., Haller S.D., Schloesser K., Tio F., Fischell T.A. Failure of a novel balloon-expandable γ-emitting (<sup>103</sup> Pd) stent to prevent edge effects Circulation. 2001;104(19):2358-2362.
Hehrlein C., Devries J., Wood T.A., Haller S.D., Arab A., Kloostra A.C., Lauer M., Fischell T.A. Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: A quantitative coronary analysis of duet and NIR stent implantation Catheterization and Cardiovascular Interventions. 2001;53(4):474-478.
Kwok O.H., Prpic R., Kinlay S., Giri S., Popma J., Fischell T. Quantitative angiographic outcome after intracoronary pullback atherectomy American Journal of Cardiology. 2001;87(9):1108-1110.
Fischell T. Visible stents: all that glitters...is it gold? The Journal of invasive cardiology. 2000;12(5):233-235.
Fischell T.A., Haddad N., Baskerville S., Foster M.T. Ultrasound thrombolysis for the treatment of thrombotic occlusion of degenerated saphenous vein grafts Catheterization and Cardiovascular Interventions. 2000;50(1):90-95.
Fischell T.A., Hehrlein C., Fischell R., Fischell D.R. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents Journal of Invasive Cardiology. 2000;12(3):162-167.
Carter A.J., Jenkins S., Sweet W., Bailey L., Jones R., Fischell T.A., Virmani R. Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis Cardiovascular Radiation Medicine. 1999;1(4):327-335.
Carter A.J., Sweet W., Bailey L., Jones R., Virmani R., Fischell T.A. Experimental results with <sup>90</sup>Yttrium beta-particle emitting radioactive stents in a porcine model of restenosis Journal of Interventional Cardiology. 1999;12(4):291-297.
Fischell T. Cleaning up the mess: new approaches to the old problem of thrombus in coronary interventions. The Journal of invasive cardiology. 1999;11(8):485-487.
Fischell T., Foster M. Adenosine for Reversal of 'No Reflow' [1] Catheterization and Cardiovascular Interventions. 1999;46(4):508.
Makkar R., Goff B., Eigler N., Sebastian M., Fischell T., Barr L., D'Haem C., Shah P., Effron M.B., Litvack F. Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot study Catheterization and Cardiovascular Interventions. 1999;48(4):430-434.
Beard B.B., Stewart J., Fischell T.A. A system for postoperative visualization and analysis of left ventricular pressure-volume loops Computers in Biology and Medicine. 1998;28(1):1-12.
Carter A., Fischell T. Current status of radioactive stents for the prevention of in-stent restenosis International Journal of Radiation Oncology Biology Physics. 1998;41(1):127-133.
Fischell T. Radioactive stents. Seminars in interventional cardiology : SIIC. 1998;3(2):51-56.
Fischell T., Hehrlein C. The radioisotope stent for the prevention of restenosis Herz. 1998;23(6):373-379.
Fischell T.A., Carter A.J., Foster M.T., Hempsall K., DeVries J., Kim D.H., Kloostra A. Reversal of 'no reflow' during vein graft stenting using high velocity boluses of intracoronary adenosine Catheterization and Cardiovascular Diagnosis. 1998;45(4):360-365.
Foster M., Atkinson J., Yeoh T., Fischell T. Histopathology of restenosis after stenting of narrowed coronary arteries after cardiac transplantation during the teenage years American Journal of Cardiology. 1997;80(3):389-393.
Janicki C., Duggan D.M., Coffey C.W., Fischell D.R., Fischell T.A. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent Medical Physics. 1997;24(3):437-445.
Misra V.K., Agirbasli M., Fischell T.A. Coronary artery vasomotion after percutaneous transluminal coronary angioplasty Clinical Cardiology. 1997;20(11):915-923.
Carter A.J., Laird J.R., Bailey L.R., Hoopes T.G., Farb A., Fischell D.R., Fischell R., Fischell T.A., Virmani R. Effects of endovascular radiation from a β-particle-emitting stent in a porcine coronary restenosis model: A dose-response study Circulation. 1996;94(10):2364-2368.
Fischell T. A beta-particle emitting radioisotope stent for the prevention of restenosis Journal of Invasive Cardiology. 1996;8(9):459-464.
Fischell T. Polymer coatings for stents: Can we judge a stent by its cover? Circulation. 1996;94(7):1494-1495.
Fischell T., Carter A., Laird J. The beta-particle-emitting radioisotope stent (isostent): Animal studies and planned clinical trials American Journal of Cardiology. 1996;78(3 A):45-50.
Fischell T.A., Drexler H. Pullback atherectomy (PAC) for the treatment of complex bifurcation coronary artery disease Catheterization and Cardiovascular Diagnosis. 1996;38(2):218-221.
Laird J.R., Carter A.J., Kufs W.M., Hoopes T.G., Farb A., Nott S.H., Fischell R.E., Fischell D.R., Virmani R., Fischell T.A. Inhibition of neointimal proliferation with low-dose irradiation from a β-particle-emitting stent Circulation. 1996;93(3):529-536.
Crocker I., McGinley P., Waksman R., Robinson K., King S., Fischell T.A., Naftilan A., Coffey C.W., Duggan D.M. β-Particle emission from stent wire [5] Circulation. 1995;92(5):1353-1354.
Saltiel F.S., Grant G., Dake M.D., Fischell T.A. Comparative Effectiveness of Intravascular Stents in Resisting Arterial Vasoconstriction: Evaluation with Use of Intact Elastic (Rabbit Aorta) and Muscular (Dog Carotid) Arteries in an ex Vivo Model Journal of Vascular and Interventional Radiology. 1995;6(3):379-385.
Zhao X., Citrin B., Miller G., Frist W., Merrill W., Fischell T., Atkinson J., Yeoh T. Association of acidic fibroblast growth factor and untreated low grade rejection with cardiac allograft vasculopathy Transplantation. 1995;59(7):1005-1010.
Abbas M.A., Afshari N.A., Stadius M.L., Kernoff R.S., Fischell T.A. External beam irradiation inhibits neointimal hyperplasia following balloon angioplasty International Journal of Cardiology. 1994;44(3):191-202.
Botas J., Clark D., Pinto F., Chenzbraun A., Fischell T. Balloon angioplasty results in increased segmental coronary distensibiliy: A likely mechanism of percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1994;23(5):1043-1052.
Drexler H., Fischell T., Pinto F., Chenzbraun A., Botas J., Cooke J., Alderman E. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: Relation to vessel wall morphology Circulation. 1994;89(4):1615-1623.
Fischell T.A., Kharma B., Fischell D.R., Loges P., Coffey C.W., Duggan D.M., Naftilan A. Low-dose, β-particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation Circulation. 1994;90(6):2956-2963.
Fleischhauer F., Yan W., Fischell T. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients Journal of the American College of Cardiology. 1993;21(4):982-989.
Pinto F., St. Goar F., Gao S., Chenzbraun A., Fischell T., Alderman E., Schroeder J., Popp R. Immediate and one-year safety of intracoronary ultrasonic imaging: Evaluation with serial quantitative angiography Circulation. 1993;88(4):1709-1714.
Pinto F.J., St. Goar F.G., Fischell T.A., Stadius M.L., Valantine H.A., Alderman E.L., Popp R.L. Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients: Evaluation with in vivo intracoronary ultrasound Circulation. 1992;85(1):69-77.
Siegel R.J., Gaines P., Procter A., Fischell T.A., Cumberland D.C. Clinical demonstration that catheter-delivered ultrasound energy reverses arterial vasoconstriction Journal of the American College of Cardiology. 1992;20(3):732-735.
Fischell T., Bausback K. Effects of luminal eccentricity on spontaneous coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty The American Journal of Cardiology. 1991;68(5):530-534.
Fischell T.A., Abbas M.A., Grant G.W., Siegel R.J. Ultrasonic energy: Effects on vascular function and integrity Circulation. 1991;84(4):1783-1795.
Fischell T.A., Stadius M.L. New technologies for the treatment of obstructive arterial disease Catheterization and Cardiovascular Diagnosis. 1991;22(3):205-233.
Kaplan A.V., Leung L., Leung W.H., Grant G.W., Ross McDougall I., Fischell T.A. Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model Circulation. 1991;84(3):1279-1288.
Leung W., Kaplan A.V., Grant G.W., Leung L., Fischell T.A. Local delivery of antithrombin agent by an infusion balloon catheter reduces platelet deposition at the site of balloon angioplasty Coronary Artery Disease. 1991;2(6):699-706.
St. Goar F.G., Giacomini J.C., Fischell T.A. Coronary occlusion following diagnostic angiography: Salvage by intracoronary stenting Catheterization and Cardiovascular Diagnosis. 1991;23(4):294-296.
Fischell T.A. Coronary artery spasm after percutaneous transluminal coronary angioplasty: Pathophysiology and clinical consequences Catheterization and Cardiovascular Diagnosis. 1990;19(1):1-3.
Fischell T.A., Bausback K.N., McDonald T.V. Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty Journal of Clinical Investigation. 1990;86(2):575-584.
Fischell T.A., Fischell R., White R.I., Chapolini R. Ex‐Vivo results using a new pullback atherectomy catheter (pac) Catheterization and Cardiovascular Diagnosis. 1990;21(4):287-291.
Fischell T.A., Grant G., Johnson D.E. Determinants of smooth muscle injury during balloon angioplasty Circulation. 1990;82(6):2170-2184.
Fischell T., Mcdonald T., Grattan M., Miller D., Stadius M. Occlusive Coronary-Artery Spasm as a Cause of Acute Myocardial Infarction after Coronary-Artery Bypass Grafting New England Journal of Medicine. 1989;320(6):400-401.
Fischell T.A., Nellessen U., Johnson D.E., Ginsburg R. Endothelium-dependent arterial vasoconstriction after balloon angioplasty Circulation. 1989;79(4):899-910.
Fischell T.A., Derby G., Tse T.M., Stadius M.L. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty: A quantitative arteriographic analysis Circulation. 1988;78(6):1323-1334.
Nellessen U., Lee T.C., Fischell T.A., Ginsburg R., Masuyama T., Alderman E.L., Schroeder J.S. Effects of acetylcholine on epicardial coronary arteries after cardiac transplantation without angiographic evidence of fixed graft narrowing The American Journal of Cardiology. 1988;62(16):1093-1097.
Nellessen U., Schnittger I., Appleton C.P., Masuyama T., Bolger A., Fischell T.A., Tye T., Popp R.L. Transesophageal two-dimensional echocardiography and color Doppler flow velocity mapping in the evaluation of cardiac valve prostheses Circulation. 1988;78(4 I):848-855.
Fischell T., Stinson E., Derby G., Swerdlow C. Curative surgery for Wolff-Parkinson-White syndrome Cardiology Board Review. 1987;4(10)
Fischell T., Stinson E., Derby G., Swerdlow C. Long-term follow-up after surgical correction of Wolff-Parkinson-White syndrome Journal of the American College of Cardiology. 1987;9(2):283-287.
Fischell T.A., Ginsburg R. Loss of endothelial-dependent arterial relaxation following balloon angioplasty Journal of Applied Cardiology. 1987;2(6):489-504.
Fischell T.A., Ginsburg R. Use of two-dimensional ultrasonic imaging to measure pharmacologically induced vasomotion in rabbit aorta Journal of Pharmacological Methods. 1986;16(4):339-347.
Fischell R., Fischell T. CLINICAL EVALUATION OF MICROCOMPUTER CONTROLLED IMPLANTABLE MEDICATION INFUSION SYSTEMS. Proceedings of the Hawaii International Conference on System Science. 1981:201-207.